Your browser doesn't support javascript.
loading
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
Katayama, Satoshi; Mori, Keiichiro; Schuettfort, Victor M; Pradere, Benjamin; Mostafaei, Hadi; Quhal, Fahad; Rajwa, Pawel; Motlagh, Reza Sari; Laukhtina, Ekaterina; Moschini, Marco; Grossmann, Nico C; Araki, Motoo; Teoh, Jeremy Yuen-Chun; Rouprêt, Morgan; Margulis, Vitaly; Enikeev, Dmitry; Karakiewicz, Pierre I; Abufaraj, Mohammad; Compérat, Eva; Nasu, Yasutomo; Shariat, Shahrokh F.
Afiliação
  • Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Schuettfort VM; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University Hospital of Tours, Tours, France.
  • Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Motlagh RS; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Moschini M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland.
  • Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
  • Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Teoh JY; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Rouprêt M; GRC 5 Predictive Onco-Uro, Urology, Sorbonne University, Pitie-Salpetriere Hospital, Paris, France.
  • Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada.
  • Abufaraj M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Research Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan.
  • Compérat E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Research Division of Urology
Eur Urol Focus ; 8(3): 761-768, 2022 05.
Article em En | MEDLINE | ID: mdl-34053904
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma in Situ / Carcinoma de Células de Transição / Neoplasias Renais Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Eur Urol Focus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma in Situ / Carcinoma de Células de Transição / Neoplasias Renais Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Eur Urol Focus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão